The report highlights the increasing prevalence of various types of cancers that are driving the demand for chemotherapy devices. Consegic Business Intelligence study also provides insights into the market's competitive landscape, market segmentation, regional outlook, and emerging technologies in the chemotherapy devices market.
The chemotherapy devices market is bifurcated into services type and end-users. Based on product, the market is segmented into catheter, cannula, pump, and others. Pump segment is sub-segmented into large volume pump, syringe pump, and elastomeric pumps. In 2022, the pump segment dominate in the overall chemotherapy devices market. The end-user segment is categorized into hospitals, clinics, and others. In 2022, the hospital segment accounted for the highest market share in the chemotherapy devices market.Get Free Sample
|Report Attributes||Report Details|
|By Product||Catheter, Cannula, Pump (Large Volume Pump, Syringe Pump, and Elastomeric Pumps), and Others|
|By End-User||Hospitals, Clinics and Others|
|By Region||North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa|
The market is dominated by certain major companies such as BD, Micrel Medical Devices SA, and ICU Medical, Inc. have a strong market position in current market circumstances. Further, the chemotherapy devices market is expected to witness significant growth in the coming years due to the rising incidence of breast cancer that majorly involves chemotherapy treatment. The market players compete for a firm market position through mergers and acquisitions, product innovations, and business strategies. Thus, evolving research and developments are expected to help market players adopt innovative ways of product creation to cater to the growing needs of various end-use industries.